MedPath

PRIORIX-TETRA POWDER AND DILUENT FOR SOLUTION FOR INJECTION

Registration Number: MAL20081816ARZ

Approved
Approval ID

744867ddc4471895

Registration Number

MAL20081816ARZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

1Units UnitsAvailable
Package Size: 1Units Units
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (4)

LIVE ATTENUATED MEASLES VIRUSActive
Monograph: live attenuated measles virus
LIVE ATTENUATED RUBELLA VIRUSActive
Monograph: live attenuated rubella virus
LIVE ATTENUATED MUMPS VIRUSActive
Monograph: live attenuated mumps virus
LIVE ATTENUATED VARICELLA OKA STRAIN VIRUSActive
Monograph: live attenuated varicella oka strain virus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PRIORIX-TETRA POWDER AND DILUENT FOR SOLUTION FOR INJECTION - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform